Transfusion Medicine

Research on Transfusion Medicine Reported by Scientists at New York Blood Center

Published in Blood Weekly, September 22nd, 2011

2011 SEP 22 -- New investigation results, "Red cells from the original JAL+ proband are also DAK+ and STEM+," are detailed in a study published in Vox Sanguinis. According to the authors of recent research from New York City, New York, "The low-prevalence Rh antigen, JAL, was named after the index case, Mr. J. Allen."

"Based on reactivity of seven multi-specific sera with his RBCs, it was apparent that they express at least one additional low-prevalence antigen," wrote K. Hue-Roye and colleagues, New York Blood Center.

The researchers concluded: "The purpose of this study was to investigate the other low-prevalence antigen(s) on...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2011-09-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry